Making the Rounds
Combination therapy improves small cell lung cancer survival
Feb. 28, 2019—Patients with stage IV small cell lung cancer lived longer when given the immunotherapy atezolizumab with chemotherapy, setting the stage for what could become the first new treatment approved in decades for this particularly aggressive form of lung cancer. Results of the study published recently in the New England Journal of Medicine showed that patients...